VAERS Explorer
Back to explore

Report #2865538

Received Oct 13, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
60 yrs
State
NJ
Recovered
Unknown
Vaccinated
Sep 2, 2025
Onset
Sep 2, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS2PJ353—

Symptoms (1)

Inappropriate schedule of product administration

Symptom narrative

got by accident an early second dose of Shingrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of drug dose administration interval too short in a 60-year-old male patient who received Herpes zoster (Shingrix) (batch number PJ353, expiry date 31-MAR-2027) for prophylaxis. Concomitant products included Varicella zoster vaccine rgE (CHO) (Shingrix). On 02-SEP-2025, the patient received the 2nd dose of Shingrix. On 02-SEP-2025, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too short (Verbatim: got by accident an early second dose of Shingrix). The outcome of the drug dose administration interval too short was not applicable.

Other medications

SHINGRIX